Charles Zhu
Stock Analyst at LifeSci Capital
(2.65)
# 2,086
Out of 5,008 analysts
26
Total ratings
45%
Success rate
23.32%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Charles Zhu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRUS Merus | Downgrades: Market Perform | $97 | $94.39 | +2.77% | 7 | Sep 30, 2025 | |
| CBIO Crescent Biopharma | Initiates: Outperform | $22 | $11.29 | +94.86% | 1 | Jun 18, 2025 | |
| RPTX Repare Therapeutics | Downgrades: Market Perform | n/a | $1.82 | - | 1 | Dec 13, 2024 | |
| TNGX Tango Therapeutics | Maintains: Buy | $18 → $8 | $7.29 | +9.74% | 3 | Nov 7, 2024 | |
| MGNX MacroGenics | Upgrades: Buy | $12 | $1.72 | +597.67% | 4 | Nov 7, 2023 | |
| NUVL Nuvalent | Initiates: Buy | $56 | $83.38 | -32.84% | 1 | Jul 24, 2023 | |
| TARA Protara Therapeutics | Assumes: Buy | $22 | $4.82 | +356.43% | 1 | Jul 10, 2023 | |
| COGT Cogent Biosciences | Reiterates: Buy | $26 | $15.44 | +68.39% | 3 | Jun 13, 2023 | |
| IDYA IDEAYA Biosciences | Reiterates: Buy | $32 | $26.92 | +18.87% | 3 | Mar 8, 2023 | |
| ZYME Zymeworks | Upgrades: Buy | $14 | $16.50 | -15.15% | 2 | May 5, 2022 |
Merus
Sep 30, 2025
Downgrades: Market Perform
Price Target: $97
Current: $94.39
Upside: +2.77%
Crescent Biopharma
Jun 18, 2025
Initiates: Outperform
Price Target: $22
Current: $11.29
Upside: +94.86%
Repare Therapeutics
Dec 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $1.82
Upside: -
Tango Therapeutics
Nov 7, 2024
Maintains: Buy
Price Target: $18 → $8
Current: $7.29
Upside: +9.74%
MacroGenics
Nov 7, 2023
Upgrades: Buy
Price Target: $12
Current: $1.72
Upside: +597.67%
Nuvalent
Jul 24, 2023
Initiates: Buy
Price Target: $56
Current: $83.38
Upside: -32.84%
Protara Therapeutics
Jul 10, 2023
Assumes: Buy
Price Target: $22
Current: $4.82
Upside: +356.43%
Cogent Biosciences
Jun 13, 2023
Reiterates: Buy
Price Target: $26
Current: $15.44
Upside: +68.39%
IDEAYA Biosciences
Mar 8, 2023
Reiterates: Buy
Price Target: $32
Current: $26.92
Upside: +18.87%
Zymeworks
May 5, 2022
Upgrades: Buy
Price Target: $14
Current: $16.50
Upside: -15.15%